Intratio
量化研究
跳转到主要内容
市场摘要
正在加载市场情报...
  • 登录
    我的账户
    登出
AI 90天预测
检测到看涨信号
██.█% 免费注册以查看

Jazz Pharmaceuticals Plc（JAZZ）AI预测

我们的AI检测到Jazz Pharmaceuticals Plc的重要信号。创建免费账户以查看精确的目标价。

✓ 免费账户 • ✓ 30天免费试用

$JAZZ 看涨信号 完整预测可用
免费注册

Jazz Pharmaceuticals Plc (JAZZ) 2025年股票预测

Jazz Pharmaceuticals Plc (JAZZ) AI股价预测与投资分析

Jazz Pharmaceuticals Plc 股价图表和技术分析

正在加载图表...

Jazz Pharmaceuticals Plc (JAZZ) - 全面股票分析与投资研究

深入了解Jazz Pharmaceuticals Plc的业务概况、财务表现、AI预测和竞争定位，以做出明智的投资决策。

分析更新于 四月 16, 2026, 8:23 a.m. (UTC)

Jazz Pharmaceuticals Plc投资摘要

在评估Jazz Pharmaceuticals Plc（JAZZ）是否代表一个引人注目的投资机会时，投资者必须考虑多种因素，包括公司的财务状况、市场地位、增长前景，以及我们的AI驱动预测模型对其近期价格走势的预测。

公司概况

Jazz Pharmaceuticals Plc (JAZZ) 位于Life Sciences行业，具体属于Pharmaceutical Preparations业务. . 该公司市值为12亿美元，属于大盘股，提供相对稳定性与增长潜力的结合。

财务表现分析

我们的全面财务分析涵盖Jazz Pharmaceuticals Plc的营收、盈利指标、资产负债表实力和现金流生成…

AI价格预测

获取Jazz Pharmaceuticals Plc的AI驱动7天、30天和90天价格预测，包括置信度评分和详细分析…

投资考量因素

专家分析Jazz Pharmaceuticals Plc是否适合您的投资目标、风险承受能力和投资期限…

继续阅读完整分析

获取Jazz Pharmaceuticals Plc的完整投资分析

免费注册
企业身份

Jazz Pharmaceuticals Plc (股票代码: JAZZ) 是在Life Sciences板块运营的知名公司，专注于Pharmaceutical Preparations行业. 该公司的股票在Nasdaq交易所公开交易.

领导层与员工

关于Jazz Pharmaceuticals Plc领导团队、员工规模和组织结构的详细信息…

市场分类

Jazz Pharmaceuticals Plc的市值分析和股票分类（超大盘、大盘、中盘、小盘）…

板块与行业分析

Jazz Pharmaceuticals Plc的深入板块动态和行业背景…

解锁完整公司概况

获取关于Jazz Pharmaceuticals Plc的完整详情

免费注册
营收与增长分析

Jazz Pharmaceuticals Plc的年营收为 $4 十亿 , 表明是一家成熟的企业，具有经证实的市场需求。

盈利能力指标

Jazz Pharmaceuticals Plc的净利率、毛利率和营业利率分析…

市场估值

Jazz Pharmaceuticals Plc的市盈率、市净率和估值倍数…

回报指标

Jazz Pharmaceuticals Plc的净资产收益率（ROE）、总资产收益率（ROA）和资本效率…

解锁财务分析

获取Jazz Pharmaceuticals Plc的完整财务指标

免费注册
AI分析可用

解锁Jazz Pharmaceuticals Plc的AI价格预测

加入10,000+投资者，使用我们准确率超过67%的AI预测

4,000+ 已分析股票
67%+ 准确率
每日 更新
开始30天免费试用 →

✓ 30天免费试用 • ✓ 随时取消

战略市场地位

Jazz Pharmaceuticals Plc在高度动态的 Pharmaceutical Preparations市场中战略竞争. 作为大盘市场参与者，该公司已建立了显著的竞争优势和市场地位。大盘公司通常受益于品牌认知度、运营规模、多元化收入来源，以及投资于研发、营销和战略收购的财务资源。这一规模类别吸引了大量的机构持股和分析师关注。

行业竞争格局

Jazz Pharmaceuticals Plc在Life Sciences板块竞争，应对该行业特有的竞争动态和市场力量。 该公司的竞争地位取决于其通过产品质量、成本效率、客户关系或其他与其特定市场细分相关的战略优势进行差异化的能力。

运营效率

该公司展示了卓越的运营效率，每年自由现金流生成达1十亿美元 . 这种强大的现金生成能力为收购、股票回购、股息增长或債务减少提供了显著的战略灵活性——同时保持保护市场地位所必需的运营投资。

资产利用效率

资产周转率为0.37倍，表明 较低的资产周转率可能反映行业的资本密集型特性或资产未充分利用。低周转率公司通常依赖强劲的利润率来产生足够的资本回报。

财务实力与杠杆

流动比率为1.86 表明有足够的流动性来履行短期义务，并有合理的缓冲。这一水平在营运资金效率和财务安全之间取得平衡。

Jazz Pharmaceuticals Plc (JAZZ) 基本面分析与内部交易数据 (季度财务报告)

全面的季度财务数据、盈利趋势、内部交易和机构持仓，用于 Jazz Pharmaceuticals Plc 股票分析.

深入了解Jazz Pharmaceuticals Plc的财务健康状况、估值指标和运营效率，以做出明智的投资决策。

了解估值指标

这些指标的含义: 估值指标有助于确定 Jazz Pharmaceuticals Plc 的股票相对于其收益、资产和市场地位是否定价合理。

如何解读: 较低的市盈率可能表明股票被低估，而较高的市盈率则表明市场对增长的预期。市净率将市值与账面价值进行比较。

对于 Jazz Pharmaceuticals Plc:

市净率 2.84x
市值 $12.25B
每股收益 $4.76
每股账面价值 $70.29
每股收入 $69.47
每股自由现金流 $21.11
理解盈利能力指标

这些指标的含义: 这些比率衡量 Jazz Pharmaceuticals Plc 将收入转化为利润并为股东创造回报的效率。

如何解读: 较高的ROE/ROA表示更好的管理效率。利润率百分比显示不同运营层面的盈利能力。

对于 Jazz Pharmaceuticals Plc: 5.1%的净资产收益率 表明有改进空间 股东价值创造.

股本回报率 5.1%
资产回报率 1.9%
投资资本回报率 2.4%
营业利润率 48.9%
净利率 47.7%
税前利润率 48.9%
理解财务健康指标

这些指标的含义: 这些比率评估Jazz Pharmaceuticals Plc履行短期债务和有效管理债务水平的能力。

如何解读: 流动比率>2通常表现良好，速动比率>1显示强劲的流动性。较低的资产负债率表明保守的债务管理。

对于 Jazz Pharmaceuticals Plc: 1.86 的流动比率 显示流动性充足.

流动比率 1.86x
速动比率 1.67x
财务杠杆 2.70x
利息保障倍数 1.0x
营运资金 $1.92B
理解现金流指标

这些指标的含义: 现金流指标揭示了Jazz Pharmaceuticals Plc从运营中产生现金并为增长计划提供资金的能力。

如何解读: 正的经营现金流至关重要。自由现金流显示可用于股息、回购或投资的资金。

对于 Jazz Pharmaceuticals Plc: $1297M 的自由现金流 为股东回报和增长投资提供灵活性.

经营现金流 $248M
自由现金流 $1.30B
资本支出 $1.05B
自由现金流/销售额 30.4%
资本支出/销售额 24.6%
理解运营效率指标

这些指标的含义: 这些比率衡量Jazz Pharmaceuticals Plc使用资产和管理营运资本的有效性。

如何解读: 较高的周转率表明资产利用效率高。较短的收款期显示有效的信用管理。

对于 Jazz Pharmaceuticals Plc: 0.37倍的资产周转率 表明有改进空间 资产利用.

资产周转率 0.37x
应收账款周转率 5.1x
固定资产周转率 21.7x
应收账款周转天数 71 天
理解财务报表数据

这些指标的含义: 来自Jazz Pharmaceuticals Plc损益表和资产负债表的关键数据，显示绝对财务表现。

如何解读: 收入显示业务规模，而利润率表明盈利能力。资产负债表项目揭示财务结构。

对于 Jazz Pharmaceuticals Plc: 年收入为$4267M，Jazz Pharmaceuticals Plc 在显著规模上运营.

损益表
总收入 $4.27B
营业收入 $225M
净收入 $220M
研发费用 $28M
销售及管理费用 $168M
资产负债表要点 (% 占资产的比例)
流动资产总额 4166%
现金及短期投资 1392%
短期债务 2120%
应收账款 831%
库存 417%
股息与股东信息
流通股份 61M
增长指标（同比）
净收入增长 47.7%
每股收益增长 2.4%

最新 Jazz Pharmaceuticals Plc 股票新闻与市场分析

影响Jazz Pharmaceuticals Plc (JAZZ) 股价和投资前景的突发新闻、分析师报告和市场更新。

更多新闻可用

免费注册以阅读所有12篇新闻文章，并了解市场最新动态。

免费注册以阅读更多

Jazz Pharmaceuticals Plc 竞争对手与同行分析 - Life Sciences 行业

Jazz Pharmaceuticals Plc在Life Sciences行业中与同行和竞争对手的比较分析，包括AI驱动的预测和关键财务指标。

公司 股票代码 90天AI预测 市值（百万美元） 市盈率 市净率
Aardvark Therapeutics, Inc. AARD ██% $111M x 1.0x
Abbvie Inc. ABBV ██% $368.71B 87.3x x
Abcellera Biologics Inc. ABCL ██% $1.16B x 1.2x
Abeona Therapeutics Inc. ABEO ██% $297M 4.2x 1.9x
Abbott Laboratories ABT ██% $176.71B 27.1x 3.4x
Arbutus Biopharma Corp ABUS ██% $863M x 11.3x
Abvc Biopharma, Inc. ABVC ██% $33M x 3.0x
Abivax S.A. ABVX ██% $9.54B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.71B 9.5x 3.0x
Adicet Bio, Inc. ACET ██% $76M x 0.5x
Aclaris Therapeutics, Inc. ACRS ██% $474M x 4.6x
Acrivon Therapeutics, Inc. ACRV ██% $65M x 0.6x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $6M x x
Acurx Pharmaceuticals, Inc. ACXP ██% $9M x 1.7x
Adagene Inc. ADAG ██% $252M x 6.7x
Adc Therapeutics Sa ADCT ██% $550M x x
Adial Pharmaceuticals, Inc. ADIL ██% $2M x 0.4x
Aditxt, Inc. ADTX ██% $400K x 0.1x
Addex Therapeutics Ltd. ADXN ██% $9M x x
Aeon Biopharma, Inc. AEON ██% $24M x x
Agios Pharmaceuticals, Inc. AGIO ██% $2.01B x 1.7x
Ainos, Inc. AIMD ██% $12M x 1.6x
Akebia Therapeutics, Inc. AKBA ██% $411M x 12.6x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $5M x 0.2x
Aldeyra Therapeutics, Inc. ALDX ██% $110M x 2.5x
Alkermes Plc. ALKS ██% $5.50B 22.8x 3.0x
Allarity Therapeutics, Inc. ALLR ██% $20M x 2.0x
Alumis Inc. ALMS ██% $3.07B x 10.2x
Alnylam Pharmaceuticals, Inc. ALNY ██% $44.13B 140.7x 55.9x
Altimmune, Inc. ALT ██% $442M x 2.0x
Alx Oncology Holdings Inc ALXO ██% $221M x 8.5x
Alzamend Neuro, Inc. ALZN ██% $4M x 1.8x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.88B x 6.2x
Amphastar Pharmaceuticals, Inc. AMPH ██% $990M 10.1x 1.3x
Amarin Corp Plc\Uk AMRN ██% $319M x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $4.09B 56.8x x
Anaptysbio, Inc ANAB ██% $1.90B x 51.1x
Anebulo Pharmaceuticals, Inc. ANEB ██% $21M x 2.6x
Ani Pharmaceuticals Inc ANIP ██% $1.72B 22.0x 3.2x
Anixa Biosciences Inc ANIX ██% $98M x 6.5x
Annexon, Inc. ANNX ██% $948M x 4.5x
Alto Neuroscience, Inc. ANRO ██% $813M x 5.4x
An2 Therapeutics, Inc. ANTX ██% $117M x 2.2x
Annovis Bio, Inc. ANVS ██% $48M x 2.8x
Apollomics Inc. APLM ██% $31M x x
Apellis Pharmaceuticals, Inc. APLS ██% $5.17B 231.0x 14.0x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $11M x 0.9x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $24M x 2.9x
Aptevo Therapeutics Inc. APVO ██% $6M x 0.4x
Aquestive Therapeutics, Inc. AQST ██% $517M x x
Arcturus Therapeutics Holdings Inc. ARCT ██% $245M x 1.2x
Ardelyx, Inc. ARDX ██% $1.54B x 9.2x
Arcutis Biotherapeutics, Inc. ARQT ██% $3.03B x 16.0x
Artelo Biosciences, Inc. ARTL ██% $4M x x
Arvinas, Inc. ARVN ██% $697M x 1.6x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $9.75B 48.2x 17.2x
Aspire Biopharma Holdings, Inc. ASBP ██% $3M x x
Assembly Biosciences, Inc. ASMB ██% $473M x 2.3x
Ascendis Pharma A/S ASND ██% $14.98B x x
Assertio Holdings, Inc. ASRT ██% $116M x 1.2x
Atai Beckley N.V. ATAI ██% $1.46B x 9.1x
Alterity Therapeutics Ltd ATHE ██% $71M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $39M x 5.0x
Atossa Therapeutics, Inc. ATOS ██% $49M x 1.3x
Avenue Therapeutics, Inc. ATXI ██% $2M x 0.9x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.12B 7.4x 3.7x
Arrivent Biopharma, Inc. AVBP ██% $1.25B x 4.1x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $459M x 1.7x
Avalo Therapeutics, Inc. AVTX ██% $304M x 3.7x
Axim Biotechnologies, Inc. AXIM ██% $2M x x
Axsome Therapeutics, Inc. AXSM ██% $9.37B x 106.1x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $4M x 0.9x
Bridgebio Pharma, Inc. BBIO ██% $15.13B x x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $751M x 1.8x
Bicara Therapeutics Inc. BCAX ██% $1.55B x 3.9x
Briacell Therapeutics Corp. BCTX ██% $34M x 1.1x
Bicycle Therapeutics Plc BCYC ██% $366M x 0.6x
Bioadaptives, Inc. BDPT ██% $130K x x
Biodexa Pharmaceuticals Plc BDRX ██% $510K x x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $17M x 8.1x
Biofrontera Inc. BFRI ██% $12M x 1.2x
Bio Green Med Solution, Inc. BGMS ██% $6M x 0.8x
Bausch Health Companies Inc. BHC ██% $2.13B 13.6x x
Bioharvest Sciences Inc. BHST ██% $97M x 3.8x
Biohaven Ltd. BHVN ██% $1.22B -4.6x 23.4x
Bioage Labs, Inc. BIOA ██% $753M x 2.8x
Bio Essence Corp BIOE ██% $15M 17.0x x
Biovie Inc. BIVI ██% $11M x 0.6x
Bioxytran, Inc BIXT ██% $4M x x
Biolinerx Ltd. BLRX ██% $11M x x
Belite Bio, Inc BLTE ██% $6.64B x 8.6x
Biomea Fusion, Inc. BMEA ██% $142M x 4.8x
Biomarin Pharmaceutical Inc BMRN ██% $10.63B 30.5x 1.8x
Bristol Myers Squibb Co BMY ██% $117.75B 16.7x 6.4x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $466M x 2.5x
Boundless Bio, Inc. BOLD ██% $37M x 0.4x
Bolt Biotherapeutics, Inc. BOLT ██% $9M x 0.4x
Bio-Path Holdings, Inc. BPTH ██% $580K x x
Bioquest Corp BQST ██% $14M x x
Barinthus Biotherapeutics Plc. BRNS ██% $24M x 0.3x
Bespoke Extracts, Inc. BSPK ██% $3M x x
Bioxcel Therapeutics, Inc. BTAI ██% $28M x x
Beyondspring Inc. BYSI ██% $68M x x
Calcimedica, Inc. CALC ██% $10M x x
Camp4 Therapeutics Corp CAMP ██% $208M -0.1x 4.4x
Can-Fite Biopharma Ltd. CANF ██% $7M x 1.3x
Capricor Therapeutics, Inc. CAPR ██% $2.01B x 6.6x
Carisma Therapeutics Inc. CARM ██% $1M 0.2x x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $499M x 2.4x
Gyre Therapeutics, Inc. CBIO ██% $607M 61.5x 5.7x
Cdt Equity Inc. CDT ██% $23M x 5.3x
Cingulate Inc. CING ██% $60M x 24.1x
Cell Source, Inc. CLCS ██% $35M x x
Clene Inc. CLNN ██% $69M x x
Cellectar Biosciences, Inc. CLRB ██% $13M x 1.5x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Clearside Biomedical, Inc. CLSDQ ██% $1M x x
Climb Bio, Inc. CLYM ██% $590M x 3.7x
Chemomab Therapeutics Ltd. CMMB ██% $12M x 1.0x
Clearmind Medicine Inc. CMND ██% $2M x x
Compass Pathways Plc CMPS ██% $768M x x
Cnbx Pharmaceuticals Inc. CNBX ██% $90K x x
Cns Pharmaceuticals, Inc. CNSP ██% $2M x 0.5x
Centessa Pharmaceuticals Plc CNTA ██% $5.91B x 11.2x
Connect Biopharma Holdings Ltd CNTB ██% $165M x 3.9x
Canton Strategic Holdings, Inc. CNTN ██% $203M x 0.5x
Context Therapeutics Inc. CNTX ██% $231M x 3.8x
Cocrystal Pharma, Inc. COCP ██% $21M x 3.3x
Cogent Biosciences, Inc. COGT ██% $5.85B x 9.2x
Collegium Pharmaceutical, Inc COLL ██% $1.11B 17.6x 3.7x
Corcept Therapeutics Inc CORT ██% $4.65B 46.7x 7.2x
Coya Therapeutics, Inc. COYA ██% $106M x 2.5x
China Pharma Holdings, Inc. CPHI ██% $26M x 3.2x
Cumberland Pharmaceuticals Inc CPIX ██% $48M x 1.9x
Cannapharmarx, Inc. CPMD ██% $3M x x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.17B 14.8x 3.3x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $176M x 1.2x
Cormedix Inc. CRMD ██% $573M 3.5x 1.4x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.80B x 3.8x
Cervomed Inc. CRVO ██% $37M x 2.1x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.27B x 20.7x
Cytomx Therapeutics, Inc. CTMX ██% $986M x 10.0x
Contineum Therapeutics, Inc. CTNM ██% $495M x 1.9x
Citius Oncology, Inc. CTOR ██% $70M x 1.2x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Ctt Pharmaceutical Holdings, Inc. CTTH ██% $4M x 5.6x
Citius Pharmaceuticals, Inc. CTXR ██% $19M x 0.2x
Cue Biopharma, Inc. CUE ██% $70M x 2.7x
Curanex Pharmaceuticals Inc CURX ██% $13M x 1.2x
Cadrenal Therapeutics, Inc. CVKD ██% $11M x 4.1x
Cv Sciences, Inc. CVSI ██% $6M x 3.8x
Cyclerion Therapeutics, Inc. CYCN ██% $13M x 1.4x
Cytodyn Inc. CYDY ██% $458M x x
Cypherpunk Technologies Inc. CYPH ██% $75M 15.7x 0.5x
Cryoport, Inc. CYRX ██% $502M 6.4x 1.0x
Cytokinetics Inc CYTK ██% $8.05B x x
Dare Bioscience, Inc. DARE ██% $26M x 9.1x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.21B x 5.0x
Decoy Therapeutics Inc. DCOY ██% $3M x 0.6x
Journey Medical Corp DERM ██% $176M x 5.5x
Diamedica Therapeutics Inc. DMAC ██% $354M x 6.3x
Damora Therapeutics, Inc. DMRA ██% $1.60B x 6.7x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $5.21B x 10.6x
Dermata Therapeutics, Inc. DRMA ██% $5M x 0.8x
Bright Minds Biosciences Inc. DRUG ██% $877M x x
Design Therapeutics, Inc. DSGN ██% $770M x 3.6x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $57M x 0.8x
Dyne Therapeutics, Inc. DYN ██% $3.30B x 3.4x
Emergent Biosolutions Inc. EBS ██% $451M 8.6x 0.9x
Edesa Biotech, Inc. EDSA ██% $45M x 3.2x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $8M x 1.0x
Elanco Animal Health Inc ELAN ██% $11.54B x 1.8x
Eledon Pharmaceuticals, Inc. ELDN ██% $249M x 3.1x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $408M 14.9x 5.1x
Elicio Therapeutics, Inc. ELTX ██% $210M x 128.2x
Enliven Therapeutics, Inc. ELVN ██% $2.61B x 5.7x
Emmaus Life Sciences, Inc. EMMA ██% $700K x x
Enlivex Ltd. ENLV ██% $196M 0.1x 0.1x
Ensysce Biosciences, Inc. ENSC ██% $5M x 1.5x
Enanta Pharmaceuticals Inc ENTA ██% $422M x 3.3x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $4M x 0.9x
Evolus, Inc. EOLS ██% $301M x x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $455M x 5.6x
Equillium, Inc. EQ ██% $126M x 4.4x
Erasca, Inc. ERAS ██% $5.17B x 15.9x
Ernexa Therapeutics Inc. ERNA ██% $6M x 2.3x
Esperion Therapeutics, Inc. ESPR ██% $557M x x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $729M x 27.9x
Earth Science Tech, Inc. ETST ██% $35M 8.5x 6.1x
Evofem Biosciences, Inc. EVFM ██% $1M 2.9x x
Evommune, Inc. EVMN ██% $970M x 4.7x
Edgewise Therapeutics, Inc. EWTX ██% $3.58B x 6.9x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $76M 11.2x 1.5x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $7M x 1.1x
Forte Biosciences, Inc. FBRX ██% $613M x 10.1x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $276M x x
Filana Therapeutics, Inc. FLNA ██% $78M x 1.0x
Amicus Therapeutics, Inc. FOLD ██% $4.49B x 16.4x
Fulcrum Therapeutics, Inc. FULC ██% $549M x 1.6x
Galectin Therapeutics Inc GALT ██% $167M x x
Gain Therapeutics, Inc. GANX ██% $90M x 4.9x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $200K x x
Cytomed Therapeutics Ltd GDTC ██% $12M x x
Geron Corp GERN ██% $1.08B x 4.8x
Gh Research Plc GHRS ██% $1.05B x x
Galmed Pharmaceuticals Ltd. GLMD ██% $5M x 0.3x
Galapagos Nv GLPG ██% $1.92B x x
Greenwich Lifesciences, Inc. GLSI ██% $357M x 163.6x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $127M x 11.0x
Genprex, Inc. GNPX ██% $12M x 1.5x
Gossamer Bio, Inc. GOSS ██% $105M x x
Geovax Labs, Inc. GOVX ██% $3M x 0.6x
Structure Therapeutics Inc. GPCR ██% $3.84B x 2.5x
Grace Therapeutics, Inc. GRCE ██% $67M x 1.0x
Gridai Technologies Corp. GRDX ██% $8M x 0.3x
Gri Bio, Inc. GRI ██% $4M x 0.6x
Galera Therapeutics, Inc. GRTX ██% $14M 0.1x 3.5x
Gsk Plc GSK ██% $115.50B x x
Gt Biopharma, Inc. GTBP ██% $12M x 2.1x
Gyre Therapeutics, Inc. GYRE ██% $732M 74.1x 6.9x
Hutchmed (China) Ltd HCM ██% $2.63B 2.9x 2.1x
Hcw Biologics Inc. HCWB ██% $3M x 1.0x
Cybin Inc. HELP ██% $274M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $450K x 0.2x
Vyome Holdings, Inc HIND ██% $16M x 6.4x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $14M x 0.4x
Hoth Therapeutics, Inc. HOTH ██% $13M x 2.2x
Werewolf Therapeutics, Inc. HOWL ██% $45M x 1.8x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.69B 10.6x 1.9x
Heron Therapeutics, Inc. /De/ HRTX ██% $181M x 12.6x
Hst Global, Inc. HSTC ██% $9M x 7.2x
Tuhura Biosciences, Inc./Nv HURA ██% $182M x 8.7x
Mindwalk Holdings Corp. HYFT ██% $60M x x
Hyperion Defi, Inc. HYPD ██% $44M x 1.1x
Ibio, Inc. IBIO ██% $73M x 1.3x
Impact Biomedical Inc. IBO ██% $73M x 5.8x
Ideaya Biosciences, Inc. IDYA ██% $2.83B x 2.8x
Inflarx N.V. IFRX ██% $87M x x
Igc Pharma, Inc. IGC ██% $30M x 4.1x
Immutep Ltd IMMP ██% $80M x x
Immix Biopharma, Inc. IMMX ██% $532M x 5.7x
Immunome Inc. IMNM ██% $2.65B x 4.2x
Imunon, Inc. IMNN ██% $12M x 1.8x
Immuron Ltd IMRN ██% $8M x x
Immuneering Corp IMRX ██% $372M x 1.7x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $145M x x
Integrated Biopharma Inc INBP ██% $9M x 0.4x
Indaptus Therapeutics, Inc. INDP ██% $6M x 1.9x
Indivior Pharmaceuticals, Inc. INDV ██% $4.07B 19.4x x
Inmed Pharmaceuticals Inc. INM ██% $2M x 0.3x
Inovio Pharmaceuticals, Inc. INO ██% $97M x 4.0x
Insmed Inc INSM ██% $31.44B x 42.6x
Inhibitor Therapeutics, Inc. INTI ██% $13M x x
Innoviva, Inc. INVA ██% $1.77B 6.5x 1.5x
Io Biotech, Inc. IOBT ██% $490K x 0.5x
Ionis Pharmaceuticals Inc IONS ██% $12.55B x 25.7x
Opus Genetics, Inc. IRD ██% $399M x 26.0x
Disc Medicine, Inc. IRON ██% $2.66B x 3.6x
Ironwood Pharmaceuticals Inc IRWD ██% $713M 29.7x x
International Stem Cell Corp ISCO ██% $1M x x
Iterum Therapeutics Plc ITRM ██% $1M x x
Inventiva S.A. IVA ██% $1.19B x x
Incannex Healthcare Inc. IXHL ██% $51M x 0.7x
Jaguar Health, Inc. JAGX ██% $6M x 1.0x
Janux Therapeutics, Inc. JANX ██% $908M x 1.0x
Jazz Pharmaceuticals Plc JAZZ ██% $12.25B x 2.8x
Jade Biosciences, Inc. JBIO ██% $950M x 2.9x
Johnson & Johnson JNJ ██% $574.57B 21.4x 7.1x
Jupiter Neurosciences, Inc. JUNS ██% $14M x 251.5x
Kala Bio, Inc. KALA ██% $181M x x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.06B x x
Kairos Pharma, Ltd. KAPA ██% $12M x 2.0x
Kaya Holdings, Inc. KAYS ██% $22M x x
Kamada Ltd KMDA ██% $487M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.41B 57.7x 6.0x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $193M x x
Keros Therapeutics, Inc. KROS ██% $357M 4.1x 1.2x
Korro Bio, Inc. KRRO ██% $197M x 3.8x
Pasithea Therapeutics Corp. KTTA ██% $17M x 0.3x
Kura Oncology, Inc. KURA ██% $795M x 4.6x
Kyntra Bio, Inc. KYNB ██% $29M 0.2x x
Kezar Life Sciences, Inc. KZR ██% $54M x 0.8x
Lb Pharmaceuticals Inc LBRX ██% $835M x 2.8x
Legend Biotech Corp LEGN ██% $3.80B x x
Lexaria Bioscience Corp. LEXX ██% $26M x 3.9x
Lifecore Biomedical, Inc. \De\ LFCR ██% $202M x x
Lifevantage Corp LFVN ██% $56M 7.1x 1.7x
Ligand Pharmaceuticals Inc LGND ██% $4.45B 35.8x 4.4x
Longeveron Inc. LGVN ██% $33M x 5.8x
Lianbio LIANY ██% $13M x 0.1x
Lftd Partners Inc. LIFD ██% $4M 44.6x 0.1x
Lipella Pharmaceuticals Inc. LIPO ██% $140K x 0.1x
Lite Strategy, Inc. LITS ██% $45M x 0.6x
Lixte Biotechnology Holdings, Inc. LIXT ██% $36M x 3.7x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Eli Lilly & Co LLY ██% $812.08B 39.3x 30.6x
Lunai Bioworks Inc. LNAI ██% $12M 7.3x x
Lipocine Inc. LPCN ██% $19M x 1.3x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $3.50B x 78.2x
Larimar Therapeutics, Inc. LRMR ██% $502M x 6.4x
Lisata Therapeutics, Inc. LSTA ██% $35M x 2.4x
Lantern Pharma Inc. LTRN ██% $27M x 4.2x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $788M x 7.3x
Lyell Immunopharma, Inc. LYEL ██% $507M x 2.0x
Maia Biotechnology, Inc. MAIA ██% $86M x 36.3x
Mustang Bio, Inc. MBIO ██% $6M x 0.6x
Moleculin Biotech, Inc. MBRX ██% $13M x 0.9x
Mbx Biosciences, Inc. MBX ██% $1.48B x 4.0x
Seres Therapeutics, Inc. MCRB ██% $84M 14.8x 1.9x
Medicus Pharma Ltd. MDCX ██% $12M x x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $11.85B x 19.7x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $223M x 4.0x
Mira Pharmaceuticals, Inc. MIRA ██% $43M x 4.2x
Mirum Pharmaceuticals, Inc. MIRM ██% $5.82B x 18.5x
Milestone Pharmaceuticals Inc. MIST ██% $216M x 5.2x
Moonlake Immunotherapeutics MLTX ██% $1.29B x 4.3x
Mineralys Therapeutics, Inc. MLYS ██% $2.23B x 3.4x
Mannkind Corp MNKD ██% $843M 143.9x x
Medicinova Inc MNOV ██% $69M x 1.7x
Monopar Therapeutics MNPR ██% $388M x 2.8x
Maplight Therapeutics, Inc. MPLT ██% $1.23B x 2.7x
Mereo Biopharma Group Plc MREO ██% $53M x 1.3x
Merck & Co., Inc. MRK ██% $300.14B 16.4x 5.7x
Marker Therapeutics, Inc. MRKR ██% $27M x 1.6x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.21B x 5.7x
Matinas Biopharma Holdings, Inc. MTNB ██% $3M x 0.7x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $8M x 1.4x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.94B x 5.8x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $469M 24.1x 2.9x
Novabridge Biosciences NBP ██% $294M x 1.1x
Nanobiotix S.A. NBTX ██% $1.49B x x
Stablecoin Development Corp NBY ██% $44M x x
Newcelx Ltd. NCEL ██% $11M x 21.2x
Nucana Plc NCNA ██% $9M x x
Minerva Neurosciences, Inc. NERV ██% $254M x x
Neuphoria Therapeutics Inc. NEUP ██% $25M x 0.9x
Neurogene Inc. NGNE ██% $322M x 1.2x
Nika Pharmaceuticals, Inc NIKA ██% $785M x x
Nektar Therapeutics NKTR ██% $2.33B x 26.0x
Nkarta, Inc. NKTX ██% $163M x 0.5x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $22M x 2.0x
Nurix Therapeutics, Inc. NRIX ██% $1.69B x 3.5x
Neurosense Therapeutics Ltd. NRSN ██% $24M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $79M x x
Neonc Technologies Holdings, Inc. NTHI ██% $134M x x
Nuvation Bio Inc. NUVB ██% $1.64B x 5.4x
Nuvalent, Inc. NUVL ██% $7.63B x 6.1x
Nuvectis Pharma, Inc. NVCT ██% $224M x 12.2x
Novartis Ag NVS ██% $292.67B x x
Northwest Biotherapeutics Inc NWBO ██% $304M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $45M x 1.3x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.89B x 2.9x
Oragenics Inc OGEN ██% $3M x 0.3x
Organigram Global Inc. OGI ██% $197M x x
Organon & Co. OGN ██% $2.26B 12.1x 3.0x
Onkure Therapeutics, Inc. OKUR ██% $62M x 1.1x
Olema Pharmaceuticals, Inc. OLMA ██% $1.33B x 2.8x
Omeros Corp OMER ██% $849M x x
Beone Medicines Ltd. ONC ██% $35.61B 124.1x 8.2x
Onconetix, Inc. ONCO ██% $650K x 0.0x
Oncolytics Biotech Inc ONCY ██% $118M x x
Opko Health, Inc. OPK ██% $879M x 0.7x
Organogenesis Holdings Inc. ORGO ██% $319M 8.6x 1.1x
Orgenesis Inc. ORGS ██% $6M x x
Oric Pharmaceuticals, Inc. ORIC ██% $1.18B x 3.1x
Oruka Therapeutics, Inc. ORKA ██% $3.27B x 6.9x
Oramed Pharmaceuticals Inc. ORMP ██% $149M 2.3x 0.8x
Os Therapies Inc OSTX ██% $61M x x
Oncotelic Therapeutics, Inc. OTLC ██% $18M x 1.9x
Ovid Therapeutics Inc. OVID ██% $447M x 3.4x
One World Products, Inc. OWPC ██% $570K x x
Phibro Animal Health Corp PAHC ██% $2.39B 28.1x 7.2x
Prestige Consumer Healthcare Inc. PBH ██% $2.71B 14.6x 1.5x
Psyence Biomedical Ltd. PBM ██% $7M x x
Puma Biotechnology, Inc. PBYI ██% $382M 12.3x 2.9x
Pacira Biosciences, Inc. PCRX ██% $977M 138.8x 1.4x
Processa Pharmaceuticals, Inc. PCSA ██% $8M x 1.4x
Procyon Corp PCYN ██% $2M x 1.0x
Pds Biotechnology Corp PDSB ██% $58M x 6.3x
Pepgen Inc. PEPG ██% $116M x 0.8x
Pfizer Inc PFE ██% $154.07B 19.8x 1.8x
Precigen, Inc. PGEN ██% $1.41B x 67.4x
Phathom Pharmaceuticals, Inc. PHAT ██% $1.01B x x
Phio Pharmaceuticals Corp. PHIO ██% $15M x 0.7x
Pharvaris N.V. PHVS ██% $1.88B x x
Protokinetix, Inc. PKTX ██% $3M x 10.8x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $80M x 0.4x
Polomar Health Services, Inc. PMHS ██% $4M x 0.6x
Promis Neurosciences Inc. PMN ██% $108M x x
Pmv Pharmaceuticals, Inc. PMVP ██% $78M x 0.8x
Purple Biotech Ltd. PPBT ██% $6M x x
Propanc Biopharma, Inc. PPCB ██% $2M x 0.2x
Praxis Precision Medicines, Inc. PRAX ██% $8.66B x 9.9x
Prf Technologies Ltd. PRFX ██% $2M x 0.3x
Perrigo Co Plc PRGO ██% $1.58B x 0.5x
Prelude Therapeutics Inc PRLD ██% $277M x 4.0x
Prophase Labs, Inc. PRPH ██% $660K x 0.1x
Proqr Therapeutics N.V. PRQR ██% $210M x x
Prothena Corp Public Ltd Co PRTA ██% $571M x 2.0x
Ptc Therapeutics, Inc. PTCT ██% $5.95B 8.7x x
Protagonist Therapeutics, Inc PTGX ██% $6.55B x 10.7x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M x x
Palatin Technologies Inc PTN ██% $36M x 3.2x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $250K x 0.1x
Pulmatrix, Inc. PULM ██% $5M x 1.2x
Provectus Biopharmaceuticals, Inc. PVCT ██% $23M x x
Palvella Therapeutics, Inc. PVLA ██% $1.85B x 66.3x
Pyxis Oncology, Inc. PYXS ██% $107M x 2.0x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $11M x 0.9x
Quantum Biopharma Ltd. QNTM ██% $18M x x
Q32 Bio Inc. QTTB ██% $86M 2.9x 2.1x
Mainz Biomed N.V. QUCY ██% $8M x 11.8x
Uniqure N.V. QURE ██% $1.07B x 5.4x
Radiopharm Theranostics Ltd RADX ██% $36M x x
Rani Therapeutics Holdings, Inc. RANI ██% $83M x 2.5x
Rapport Therapeutics, Inc. RAPP ██% $1.73B x 3.6x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.37B x x
Rocket Pharmaceuticals, Inc. RCKT ██% $394M x 1.4x
Arcus Biosciences, Inc. RCUS ██% $2.88B x 4.6x
Dr Reddys Laboratories Ltd RDY ██% $10.96B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $79.03B 17.5x 2.5x
Revelation Biosciences, Inc. REVB ██% $4M x 0.5x
Rafael Holdings, Inc. RFL ██% $62M x 0.8x
Regen Biopharma Inc RGBP ██% $130K x x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $575M 1.6x 1.5x
Relmada Therapeutics, Inc. RLMD ██% $754M x 8.7x
Rallybio Corp RLYB ██% $44M x 0.8x
Retrieve Medical Holdings, Inc. RMHI ██% $26M x x
Rockwell Medical, Inc. RMTI ██% $37M x 1.0x
Avidity Biosciences, Inc. RNA ██% $206M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $154M x x
Transcode Therapeutics, Inc. RNAZ ██% $7M x 5.2x
Rein Therapeutics, Inc. RNTX ██% $45M x 2.7x
Renovorx, Inc. RNXT ██% $49M x 9.0x
Roivant Sciences Ltd. ROIV ██% $20.55B x 4.8x
Royalty Pharma Plc RPRX ██% $28.94B 37.5x 4.5x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $11M x 1.3x
Rhythm Pharmaceuticals, Inc. RYTM ██% $5.83B x 42.0x
Rezolute, Inc. RZLT ██% $339M x 2.7x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $5M x 0.2x
Scienture Holdings, Inc. SCNX ██% $14M x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $610K x x
Scynexis Inc SCYX ██% $44M x 0.9x
Schrodinger, Inc. SDGR ██% $875M x 2.4x
Septerna, Inc. SEPN ██% $1.08B x 2.8x
Serina Therapeutics, Inc. SER ██% $24M x x
Sagimet Biosciences Inc. SGMT ██% $175M x 1.6x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $4M x 1.8x
Siga Technologies Inc SIGA ██% $328M 14.1x 1.7x
Silo Pharma, Inc. SILO ██% $7M x 1.1x
Sionna Therapeutics, Inc. SION ██% $1.99B x 6.5x
Skinvisible, Inc. SKVI ██% $2M x x
Skye Bioscience, Inc. SKYE ██% $27M x 1.4x
Sol-Gel Technologies Ltd. SLGL ██% $241M x 10.6x
Silence Therapeutics Plc SLN ██% $284M x 4.6x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.75B 131.8x 6.1x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $855M x 12.1x
Summit Therapeutics Inc. SMMT ██% $16.86B x 25.6x
Semnur Pharmaceuticals, Inc. SMNR ██% $1.84B x x
Syndax Pharmaceuticals Inc SNDX ██% $2.16B x 33.4x
Soligenix, Inc. SNGX ██% $11M x 2.2x
Sibannac, Inc. SNNC ██% $1M x x
Sensei Biotherapeutics, Inc. SNSE ██% $40M x 2.2x
Sanofi SNY ██% $116.10B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $89M x 2.1x
Scisparc Ltd. SPRC ██% $2M x x
Spero Therapeutics, Inc. SPRO ██% $157M 18.3x 2.7x
Ars Pharmaceuticals, Inc. SPRY ██% $794M x 7.0x
Sarepta Therapeutics, Inc. SRPT ██% $2.28B x 2.0x
Stoke Therapeutics, Inc. STOK ██% $2.14B x 6.1x
Shattuck Labs, Inc. STTK ██% $512M x 6.2x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.90B x 2.7x
Savara Inc SVRA ██% $1.26B x 6.2x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $5M x 1.5x
Synlogic, Inc. SYBX ██% $7M x 0.6x
Spyre Therapeutics, Inc. SYRE ██% $4.93B x 6.9x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $56.71B x x
Theravance Biopharma, Inc. TBPH ██% $844M 8.0x 2.9x
Alaunos Therapeutics, Inc. TCRT ██% $7M x 3.3x
Telomir Pharmaceuticals, Inc. TELO ██% $44M x 7.5x
Tenax Therapeutics, Inc. TENX ██% $245M x 2.5x
Terns Pharmaceuticals, Inc. TERN ██% $5.92B x 5.9x
Teva Pharmaceutical Industries Ltd TEVA ██% $36.01B 25.5x 4.6x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $5.32B 11.9x 8.2x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $41M x 2.4x
Telix Pharmaceuticals Ltd TLX ██% $3.71B x x
Tango Therapeutics, Inc. TNGX ██% $3.31B x 9.6x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $183M x 0.7x
Theriva Biologics, Inc. TOVX ██% $11M x 0.7x
Tempest Therapeutics, Inc. TPST ██% $31M x 4.7x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $528M x 1.7x
Trevi Therapeutics, Inc. TRVI ██% $1.78B x 9.7x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Turn Therapeutics Inc. TTRX ██% $98M x 20.8x
Tvardi Therapeutics, Inc. TVRD ██% $30M x 1.4x
Travere Therapeutics, Inc. TVTX ██% $3.72B x 32.4x
Therapeuticsmd, Inc. TXMD ██% $24M x 0.9x
Tyra Biosciences, Inc. TYRA ██% $1.89B x 7.3x
Unicycive Therapeutics, Inc. UNCY ██% $175M x 5.8x
Upstream Bio, Inc. UPB ██% $536M x 1.6x
Urogen Pharma Ltd. URGN ██% $1.02B x x
United Therapeutics Corp UTHR ██% $25.32B 19.0x 3.6x
Vaccinex, Inc. VCNX ██% $3M x x
Vera Therapeutics, Inc. VERA ██% $3.06B x 5.1x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Vg Life Sciences Inc. VGLS ██% $4M x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $4.04B x 6.3x
Vanda Pharmaceuticals Inc. VNDA ██% $427M x 1.3x
Verrica Pharmaceuticals Inc. VRCA ██% $100M x 4.0x
Viridian Therapeutics, Inc.\De VRDN ██% $1.53B x 2.1x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $111.63B 28.2x 6.0x
Verastem, Inc. VSTM ██% $557M x 9.7x
Vistagen Therapeutics, Inc. VTGN ██% $25M x 0.5x
Viatris Inc VTRS ██% $16.18B x 1.1x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $20M x 0.7x
Whitehawk Therapeutics, Inc. WHWK ██% $182M x 1.3x
Wave Life Sciences Ltd. WVE ██% $1.40B x 2.7x
Xenetic Biosciences, Inc. XBIO ██% $7M x 1.0x
Xbiotech Inc. XBIT ██% $75M x 0.5x
Exicure, Inc. XCUR ██% $24M x 6.1x
Xenon Pharmaceuticals Inc. XENE ██% $5.61B x 9.6x
Xeris Biopharma Holdings, Inc. XERS ██% $1.01B 1824.1x 73.8x
Xilio Therapeutics, Inc. XLO ██% $50M x 1.4x
Xencor Inc XNCR ██% $889M x 1.4x
Xoma Royalty Corp XOMA ██% $471M 14.8x 5.6x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $6M x x
Zenas Biopharma, Inc. ZBIO ██% $1.29B x 5.3x
Zai Lab Ltd ZLAB ██% $2.59B x 3.6x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $353M x 1.6x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $51.52B 19.3x 15.5x
Zevra Therapeutics, Inc. ZVRA ██% $573M 6.9x 3.7x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
显示所有预测 查看所有竞争对手的精确%预测
免费注册

常见问题 - Jazz Pharmaceuticals Plc 股票预测

Jazz Pharmaceuticals Plc的股票预测有多准确？

我们的AI模型对JAZZ预测展示了-9%的历史准确率，基于超过10年市场数据训练的先进机器学习算法。

哪些因素影响Jazz Pharmaceuticals Plc的股价预测？

我们的分析考虑了Jazz Pharmaceuticals Plc的财务指标、Life Sciences行业趋势、市场情绪、技术指标、盈利数据以及影响股票表现的宏观经济因素。

Jazz Pharmaceuticals Plc在2025年是一项好的投资吗？

根据我们的AI分析，Jazz Pharmaceuticals Plc显示 各种市场情况的潜力. 在做出投资决策之前，请考虑您的风险承受能力、投资时间表和投资组合多样化。

Jazz Pharmaceuticals Plc的预测多久更新一次？

Jazz Pharmaceuticals Plc的股票预测每天使用实时市场数据更新，确保您获得最新的AI驱动的预测和投资见解。

想要Jazz Pharmaceuticals Plc的更简洁视图吗？

在AI Stock Finder上查看简化分析 →

我的投资组合

投资仪表板

正在加载您的投资组合...